The Effect of Virtual Reality on Fatigue and Functional Capacity in Patients With MS

https://clinicaltrials.gov/study/NCT06987994?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

An Extension Clinical Study of the Efficacy and Safety of BCD-132 in Patients With Multiple Sclerosis Who Previously Received Therapy in Clinical Studies of JSC BIOCAD

https://clinicaltrials.gov/study/NCT06987851?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

Effect of a Mobile Health App on Pain and Quality of Life in Patients With Neuropathic Pain in Multiple Sclerosis

https://clinicaltrials.gov/study/NCT06982742?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis

https://clinicaltrials.gov/study/NCT06981013?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS

Hanmi Pharmaceutical partners with MSD for clinical trials on combination cancer therapy, focusing on HM16390 and Keytruda to potentially improve outcomes for advanced solid tumor patients.
#YonhapInfomax #HanmiPharmaceutical #MSD #ClinicalTrial #CancerTherapy #Immunotherapy #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=63794
Hanmi Pharm Collaborates with US-based MSD for Clinical Research on Combination Cancer Therapy

Hanmi Pharmaceutical partners with MSD for clinical trials on combination cancer therapy, focusing on HM16390 and Keytruda to potentially improve outcomes for advanced solid tumor patients.

Yonhap Infomax

Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.

https://clinicaltrials.gov/study/NCT06975605?cond=Multiple+Sclerosis

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS